Villarreal AE, Pérez-Lao AR, Oviedo DC, Grajales S, Carreira MB, Britton GB

Language: English
References: 21
Page: 54-58
PDF size: 156.71 Kb.

ABSTRACT

The Panama Aging Research Initiative is a cohort study of 423 adults aged ≥65 years recruited from an outpatient geriatric department of Panama’s largest public hospital, the Social Security Fund’s Dr Arnulfo Arias Madrid Hospital Complex (Complejo Hospitalario Dr Arnulfo Arias Madrid de la Caja de Seguro Social). The study provides the first reports of modifiable and non-modifiable risk factors of cognitive impairment and dementia, as well as various health conditions common among older adults in Panama, including chronic illnesses, polypharmacy and rates of comorbidity. The initial study, conducted September 2012–May 2016, included a clinical interview; physical assessments of body mass index and handgrip strength; and cognitive testing, plus non-fasting blood draws for measurements of genetic (Apolipoprotein E genotype) and blood-based biological markers.
Information was collected regarding limitations in activities of daily living, symptoms of depression and fall incidents. A subsample of participants provided cerebrospinal fluid to measure proteins related to Alzheimer’s disease; another subsample underwent ultrasonography and electroencephalography.
This report describes the general study design and highlights lessons learned and future directions. In particular, drawing on lessons learned from this clinical research, a community-based prospective cohort study is currently under way among older adults in Panama to validate a blood-based biomarker profile for detecting mild cognitive impairment and Alzheimer’s disease, as well as risk factors for cognitive decline.

REFERENCES

1. World Health Organization. Report of the World Health Organization. Active ageing: a policy framework [Internet]. World Health Organization: Geneva; 2002 [cited 2018 Jan 5]. 59. Available from: https://apps.who.int/iris/hand le/10665/67215

2. Aranco N, Stampini M, Ibarrarán P, Medellín N. Panorama de envejecimiento y dependencia en América Latina y el Caribe [Internet]. Washington, D.C.: Inter-American Development Bank; 2018 Jan [cited 2018 Feb 5]. 98 p. Available from: https://publications.iadb.org/en/panorama -de-envejecimiento-y-dependencia-en-america -latina-y-el-caribe. Spanish.

3. Chen C, Zissimopoulos JM. Racial and ethnic differences in trends in dementia prevalence and risk factors in the United States. Alzheimers Dement (NY). 2018 Oct 5;4:510–20.

4. Villarreal AE, Grajales S, López L, Britton GB; Panama Aging Research I. Cognitive impairment, depression, and cooccurrence of both among the elderly in Panama: differential associations with multimorbidity and functional limitations. Biomed Res Int. 2015;2015:718701.

5. Villarreal AE, O’Bryant SE, Edwards M, Grajales S, Britton GB; Panama Aging Research I. Serum-based protein profi les of Alzheimer’s disease and mild cognitive impairment in elderly Hispanics. Neurodegener Dis Manag. 2016 Jun;6(3)203–13.

6. Villarreal AE, Grajales S, O’Bryant SE, Edwards M, López L, Montalvan A, et al. Characterization of Alzheimer’s Disease and mild cognitive impairment in older adults in Panama. J Alzheimers Dis. 2016 Oct 4;54(3):897–901.

7. Villarreal AE, Grajales S, López L, Oviedo DC, Carreira MB, Gómez LA, et al. Limitations in activities of daily living among dementiafree older adults in Panama. Ageing Int. 2018 Jun;43(2):237–53.

8. Oviedo DC, Lezcano H, Pérez AR, Villarreal AE, Carreira MB, Isaza B, et al. Vascular biomarkers and ApoE4 expression in mild cognitive impairment and Alzheimer’s disease. AIMS Neurosci. 2018 Jun 16;5(2):148–61.

9. World Medical Association Declaration of Helsinki. Ethical Principles for Medical Research Involving Human Subjects. Bull World Health Organ. 2001;79(4): 373–4.

10. Folstein MF, Folstein SE, McHugh PR. “Minimental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975 Nov;12(3):189–98.

11. Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res. 1982;17(1):37–49.

12. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer’s disease: report of the NINCDSADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology. 1984 Jul;34(7):939–44.

13. Petersen RC, Negash S. Mild cognitive impairment: an overview. CNS Spectr. 2008 Jan;13(1):45–53.

14. Reisberg B, Ferris SH, de Leon MJ, Crook T. The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry. 1982 Sep;139(9):1136–9.

15. O’Bryant SE, Xiao G, Zhang F, Edwards M, German DC, Yin X, et al. Validation of a serum screen for Alzheimer’s disease across assay platforms, species, and tissues. J Alzheimers Dis. 2014;42(4):1325–35.

16. O’Bryant SE, Edwards M, Johnson L, Hall J, Villarreal AE, Britton GB, et al. A blood screening test for Alzheimer’s disease. Alzheimers Dement (Amst). 2016 Jun 25;3:83–90.

17. O’Bryant SE, Xiao G, Barber R, Reisch J, Doody R, Fairchild T, et al. A serum protein-based algorithm for the detection of Alzheimer disease. Arch Neurol. 2010 Sep;67(9):1077–81.

18. Arizaga RL, Gogorza RE, Allegri RF, Baumann PD, Morales MC, Harris P, et al. Cognitive impairment and risk factor prevalence in a population over 60 in Argentina. Dement Neuropsychol. 2014 Oct–Dec;8(4):364–70.

19. Lezcano H, Villareal AE, Grajales S, Montalván A, Vásquez V, Britton GB. Utility of the geriatric depression scale in older adults attending the geriatric service of the Caja de Seguro Social. Rev Méd Cient. 2017;30:4–10.

20. Prince M, Acosta D, Ferri CP, Guerra M, Huang Y, Rodríguez JJ, et al. Dementia incidence and mortality in middle-income countries, and associations with indicators of cognitive reserve: a 10/66 Dementia Research Group population-based cohort study. Lancet. 2012 Jul 7;380(9836):50–8.

21. Blennow K, de León MJ, Zetterberg H. Alzheimer’s disease. Lancet. 2006 Jul 29;368(9533): 387–403.